New targeted therapy duo enters human trials for advanced breast cancer
Disease control
Terminated
This early-phase study tests two related drugs: one to help see tumors on scans (68Ga-R11228) and another to deliver radiation directly to cancer cells (177Lu-R11228). It is for people with advanced hormone-receptor positive breast cancer that has spread or come back. The main go…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC